Tag
Cancer Treatment
21 genetic variants with this tag.
| RSID | Gene | Description | Category | ||
|---|---|---|---|---|---|
| rs1113129 | CYP2C8 | Intronic tagging SNP for CYP2C8 haplotype C, a low-activity haplotype associa... | Pharmacogenomics | Moderate | |
| rs1051298 | SLC19A1 SLC19A1 3'UTR variant (c.*746C>T) | 3'UTR variant in the folate transporter gene affecting pemetrexed toxicity ri... | Methylation & Detox | Moderate | |
| rs116855232 | NUDT15 Arg139Cys | Nucleotide diphosphatase that inactivates toxic thiopurine metabolites; reduc... | Pharmacogenomics | Established | |
| rs12721627 | CYP3A4 *16 | Missense variant reducing CYP3A4 enzyme activity by 50–74% depending on subst... | Pharmacogenomics | Moderate | |
| rs12721629 | CYP3A4 *16B | Missense variant causing substrate-dependent reduced CYP3A4 activity, most pr... | Pharmacogenomics | Moderate | |
| rs1341162 | CYP2C8 | Intronic CYP2C8 haplotype-tagging variant linked to altered drug metabolism c... | Pharmacogenomics | Moderate | |
| rs1341164 | CYP2C8 | Intronic CYP2C8 variant tagging a haplotype associated with altered taxane dr... | Pharmacogenomics | Emerging | |
| rs4775936 | CYP19A1 CYP19A1 Promoter Region Variant (Aro1) | Regulatory variant in the CYP19A1 aromatase gene that alters estrogen biosynt... | Reproductive Hormones | Moderate | |
| rs1934951 | CYP2C8 | Intronic CYP2C8 variant associated with paclitaxel-induced toxicity and bisph... | Pharmacogenomics | Moderate | |
| rs396991 | FCGR3A V158F | Missense variant in Fc gamma receptor IIIa (CD16a) that determines NK cell Ig... | Innate Immunity & Infection Defense | Strong | |
| rs1934980 | CYP2C8 | Intronic CYP2C8 variant linked to altered enzyme expression and associated wi... | Pharmacogenomics | Moderate | |
| rs28399433 | CYP2A6 *9 (TATA box) | Promoter variant that reduces CYP2A6 expression by ~50%, slowing nicotine met... | Pharmacogenomics | Strong | |
| rs28399444 | CYP2A6 *7 (I471T) | CYP2A6*7 missense variant that nearly abolishes nicotine C-oxidase activity; ... | Pharmacogenomics | Established | |
| rs3788189 | SLC19A1 SLC19A1 IVS2 variant | Intronic variant in the folate transporter gene associated with pemetrexed tr... | Methylation & Detox | Emerging | |
| rs3918290 | DPYD *2A | Most critical pharmacogenomic variant causing complete loss of DPD enzyme fun... | Pharmacogenomics | Established | |
| rs4148323 | UGT1A1 *6 Gly71Arg | Phase II glucuronidation enzyme that metabolizes bilirubin and many drugs inc... | Pharmacogenomics | Established | |
| rs55886062 | DPYD *13 | No-function DPYD star allele (I560S) causing severe DPD deficiency; one of fo... | Pharmacogenomics | Established | |
| rs56038477 | DPYD HapB3 tag (c.1236G>A, E412E) | Synonymous exon-11 tag SNP for the DPYD HapB3 haplotype; benign on its own bu... | Pharmacogenomics | Established | |
| rs67376798 | DPYD D949V | Decreased-function variant reducing DPD enzyme activity ~30%, requiring 50% f... | Pharmacogenomics | Established | |
| rs67784355 | CYP3A4 *11 (Thr363Met) | Rare missense variant in CYP3A4 that reduces protein expression and enzymatic... | Pharmacogenomics | Emerging | |
| rs75017182 | DPYD HapB3 (c.1129-5923C>G) | Deep intronic splice-site variant that is the functional driver of the DPYD H... | Pharmacogenomics | Established |